| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Christophe Arbetengels | Med | 2026-10-01 | 12,679 | $2.76 | $34.99kSell |
| Gregory L. Weaver | CFO | 2026-10-01 | 4,379 | $2.76 | $12.09kSell |
| Linda M. Richardson | CCO | 2026-09-16 | 6,826 | $3.24 | $22.12kSell |
| Jerome Benedict Durso | CEO;Pres | 2026-08-13 | 15,000 | $2.95 | $44.25kBuy |
| Gregory L. Weaver | CFO | 2026-07-31 | 1,753 | $2.41 | $4.23kBuy |
| M. Scot Roberts | CSci | 2026-07-31 | 875 | $2.41 | $2.11kBuy |
| John Gill | Director | 2026-04-06 | 9,200 | $3.41 | $31.35kBuy |
| Jerome Benedict Durso | President and CEO | 2026-04-01 | 15,000 | $3.14 | $47.10kBuy |
| Gregory L. Weaver | Chief Financial Officer | 2026-04-01 | 10,000 | $3.15 | $31.50kBuy |
| Jerome Benedict Durso | President and CEO | 2026-03-06 | 20,000 | $3.54 | $70.78kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Prescott Group Capital Management LLC | 10.20% | 19,837,273 | $43.64M | Insider |
| Novartis Bioventures Ltd | 4.29% | 8,345,145 | $18.36M | Insider |
| Mpm Bioventures III LLC | 3.26% | 6,347,614 | $13.96M | Insider |
| Luke Evnin | 3.26% | 6,347,614 | $13.96M | Insider |
| Healthcare Ventures VII LP | 2.25% | 4,378,057 | $9.63M | Insider |
| Venrock Healthcare Capital Partners III LP | 1.80% | 3,500,000 | $7.70M | Insider |
| James H. Cavanaugh | 1.71% | 3,317,243 | $7.30M | Insider |
| Velocity Pharmaceutical Holdings LLC | 0.87% | 1,687,250 | $3.71M | Insider |
| Derace L. Schaffer | 0.83% | 1,619,557 | $3.56M | Insider |
| Elizabeth Czerepak | 0.68% | 1,320,087 | $2.90M | Insider |